4-AMINO-6-FLUORONICOTINIC ACID, 95.0%, 100mg

1-(4-fluoro-3-(trifluoromethyl)phenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 250mg

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 5mg

3-((Benzyloxy)methyl)-2-(4-methoxybenzyl)-3,4-dihydro-2H-1,2-thiazine 1,1-dioxide, 98%, 1g

(2E)-3-(3-ethoxy-4-isopropoxyphenyl)acrylic acid, 1g

3-(Bromomethyl)-4-methylpyridine hydrobromide, 95.0%, 5g

1-tert-butyl-4-methyl-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 500mg

3-Amino-3-methyl-butyric acid, 97.0%, 10g

4-(Benzyloxy)pyridin-2(1H)-one, 97.0%, 5g

5-Bromo-2-methylisonicotinaldehyde, 97%, 100mg

(1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl Succinimidyl Carbonate>90.0%(qNMR)100mg

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid, 98%, 1g

((6-Bromohexyl)oxy)(tert-butyl)dimethylsilane, 95%, 25g